Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jeff Garro is an analyst at Stephens & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/30/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/30/2024 | EVH | Buy Now | Evolent Health | $23.40 | 79.49% | $42 → $42 | Reiterates | Overweight → Overweight | Get Alert |
| 05/31/2024 | PHR | Buy Now | Phreesia | $25.27 | 10.8% | $28 → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 03/22/2024 | PHR | Buy Now | Phreesia | $25.27 | 10.8% | → $28 | Reiterates | Overweight → Overweight | Get Alert |
| 11/14/2023 | MDRX | Buy Now | Veradigm | $9.65 | 34.65% | → $13 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 11/10/2023 | CPSI | Buy Now | CPSI | — | — | $24 → $14 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | CPSI | Buy Now | CPSI | — | — | → $24 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 10/11/2023 | CERT | Buy Now | Certara | $15.86 | 26.1% | → $20 | Reiterates | Overweight → Overweight | Get Alert |
| 10/10/2023 | MDRX | Buy Now | Veradigm | $9.65 | 34.65% | → $13 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 10/05/2023 | ACCD | Buy Now | Accolade | $4.02 | 347.76% | → $18 | Reiterates | Overweight → Overweight | Get Alert |
| 09/08/2023 | PHR | Buy Now | Phreesia | $25.27 | 38.5% | → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | PHR | Buy Now | Phreesia | $25.27 | 46.42% | → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 08/15/2023 | PHR | Buy Now | Phreesia | $25.27 | 46.42% | → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 08/14/2023 | ACCD | Buy Now | Accolade | $4.02 | 347.76% | → $18 | Reiterates | Overweight → Overweight | Get Alert |
| 07/26/2023 | TDOC | Buy Now | Teladoc Health | $9.53 | 193.66% | → $28 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/25/2023 | NXGN | Buy Now | NextGen Healthcare | — | — | → $24 | Reiterates | Overweight → Overweight | Get Alert |
| 06/06/2023 | PHR | Buy Now | Phreesia | $25.27 | 46.42% | → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 06/01/2023 | PHR | Buy Now | Phreesia | $25.27 | 46.42% | → $37 | Reiterates | Overweight → Overweight | Get Alert |
| 05/17/2023 | NXGN | Buy Now | NextGen Healthcare | — | — | → $24 | Reiterates | Overweight → Overweight | Get Alert |
| 05/04/2023 | EVH | Buy Now | Evolent Health | $23.40 | 70.94% | → $40 | Reiterates | → Overweight | Get Alert |
| 04/12/2023 | EVH | Buy Now | Evolent Health | $23.40 | 70.94% | → $40 | Initiates | → Overweight | Get Alert |
| 04/12/2023 | RCM | Buy Now | R1 RCM | $12.74 | 41.29% | → $18 | Initiates | → Overweight | Get Alert |
| 04/12/2023 | TDOC | Buy Now | Teladoc Health | $9.53 | 162.2% | → $25 | Initiates | → Equal-Weight | Get Alert |
| 04/12/2023 | PRVA | Buy Now | Privia Health Gr | $20.96 | 57.44% | → $33 | Initiates | → Overweight | Get Alert |
| 04/12/2023 | PHR | Buy Now | Phreesia | $25.27 | 46.42% | → $37 | Initiates | → Overweight | Get Alert |
| 04/12/2023 | NXGN | Buy Now | NextGen Healthcare | — | — | → $24 | Initiates | → Overweight | Get Alert |
| 04/12/2023 | CPSI | Buy Now | CPSI | — | — | → $30 | Initiates | → Equal-Weight | Get Alert |
| 04/12/2023 | CERT | Buy Now | Certara | $15.86 | 76.54% | → $28 | Initiates | → Overweight | Get Alert |
| 04/12/2023 | MDRX | Buy Now | Veradigm | $9.65 | 34.65% | → $13 | Initiates | → Equal-Weight | Get Alert |
| 04/12/2023 | ACCD | Buy Now | Accolade | $4.02 | 347.76% | → $18 | Initiates | → Overweight | Get Alert |
| 08/11/2022 | BHG | Buy Now | Bright Health Gr | — | — | $400 → $240 | Maintains | Overweight | Get Alert |
| 08/10/2022 | CERT | Buy Now | Certara | $15.86 | 57.63% | $28 → $25 | Maintains | Overweight | Get Alert |
| 08/10/2022 | OPRX | Buy Now | OptimizeRx | $11.15 | 43.5% | $29 → $16 | Maintains | Neutral | Get Alert |
| 08/05/2022 | ALHC | Buy Now | Alignment Healthcare | $8.88 | 125.23% | $15 → $20 | Maintains | Overweight | Get Alert |
| 07/01/2022 | OPRX | Buy Now | OptimizeRx | $11.15 | 160.09% | → $29 | Initiates | → Neutral | Get Alert |
| 07/01/2022 | CERT | Buy Now | Certara | $15.86 | 76.54% | → $28 | Initiates | → Overweight | Get Alert |
| 06/10/2022 | MDRX | Buy Now | Veradigm | $9.65 | 76.07% | $19 → $17 | Maintains | Neutral | Get Alert |
| 05/11/2022 | INNV | Buy Now | InnovAge Holding | $6.35 | -38.58% | $5 → $3.9 | Maintains | Underweight | Get Alert |
| 05/06/2022 | MDRX | Buy Now | Veradigm | $9.65 | 96.79% | $22 → $19 | Maintains | Neutral | Get Alert |
| 05/06/2022 | SLQT | Buy Now | SelectQuote | $4.05 | -26.02% | $4 → $3 | Maintains | Neutral | Get Alert |
| 04/29/2022 | ACCD | Buy Now | Accolade | $4.02 | 173.63% | $22 → $11 | Maintains | Overweight | Get Alert |
| 04/29/2022 | IQV | Buy Now | IQVIA Hldgs | $244.48 | 4.3% | $231 → $255 | Upgrade | Neutral → Overweight | Get Alert |
| 04/20/2022 | INNV | Buy Now | InnovAge Holding | $6.35 | -21.26% | $4 → $5 | Downgrade | Neutral → Underweight | Get Alert |
| 03/18/2022 | MDRX | Buy Now | Veradigm | $9.65 | 127.86% | $19 → $22 | Maintains | Neutral | Get Alert |
| 03/03/2022 | BHG | Buy Now | Bright Health Gr | — | — | $800 → $400 | Maintains | Overweight | Get Alert |
| 02/24/2022 | ALHC | Buy Now | Alignment Healthcare | $8.88 | 68.92% | $25 → $15 | Maintains | Overweight | Get Alert |
| 02/08/2022 | SLQT | Buy Now | SelectQuote | $4.05 | -1.36% | $20 → $4 | Downgrade | Overweight → Neutral | Get Alert |
